UROV Insider Trading Activity and SEC Form 4 Filings
UROV insider trading summary
No open-market insider purchases or sales of Urovant Sciences Ltd. (UROV) have been reported on SEC Form 4 in the past 12 months.
Latest UROV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 19, 2020 | Sumitomo Chemical Co., Ltd. | Insider | Buy | $198K (15,165 @ $13.08) |
| Feb 19, 2020 | Sumitomo Chemical Co., Ltd. | Insider | Buy | $984K (75,212 @ $13.08) |
| Feb 19, 2020 | Dainippon Sumitomo Pharma Co Ltd | Insider | Buy | $198K (15,165 @ $13.08) |
| Feb 19, 2020 | Dainippon Sumitomo Pharma Co Ltd | Insider | Buy | $168K (12,873 @ $13.08) |
| Feb 19, 2020 | Sumitovant Biopharma Ltd. | 10% Owner | Buy | $198K (15,165 @ $13.08) |
| Feb 19, 2020 | Sumitovant Biopharma Ltd. | 10% Owner | Buy | $984K (75,212 @ $13.08) |
| Feb 19, 2020 | Sumitovant Biopharma Ltd. | 10% Owner | Buy | $168K (12,873 @ $13.08) |
| Feb 19, 2020 | Sumitomo Chemical Co., Ltd. | Insider | Buy | $168K (12,873 @ $13.08) |
| Feb 19, 2020 | Dainippon Sumitomo Pharma Co Ltd | Insider | Buy | $984K (75,212 @ $13.08) |
| Dec 27, 2019 | Roivant Sciences Ltd. | 10% Owner | Sell | $0 (22,860,013 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.